We previously described the molecular cloning of a human monoclonal antibody Fab fragment named PN-SIA49 [26, 37] . An anti-influenza A antibody directed against H1N1 subtype HA, named RB62, and an anti-HCV E2 glycoprotein antibody, named e137 [28] , produced and purified with an identical procedure were used as controls in all experiments.